Influenza Virus Propagation in Embryonated Chicken Eggs

被引:80
作者
Brauer, Rena [1 ]
Chen, Peter [1 ]
机构
[1] Cedars Sinai Med Ctr, Womens Guild Lung Inst, Div Pulm & Crit Care Med, Dept Med, Los Angeles, CA 90048 USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2015年 / 97期
关键词
Infection; Issue; 97; Influenza; A/PR/8/34; chicken eggs; allantoic fluid; virus growth; influenza virus propagation; REPLICATION;
D O I
10.3791/52421
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Influenza infection is associated with about 36,000 deaths and more than 200,000 hospitalizations every year in the United States. The continuous emergence of new influenza virus strains due to mutation and re-assortment complicates the control of the virus and necessitates the permanent development of novel drugs and vaccines. The laboratory-based study of influenza requires a reliable and cost-effective method for the propagation of the virus. Here, a comprehensive protocol is provided for influenza A virus propagation in fertile chicken eggs, which consistently yields high titer viral stocks. In brief, serum pathogen-free (SPF) fertilized chicken eggs are incubated at 37 degrees C and 55-60% humidity for 10 - 11 days. Over this period, embryo development can be easily monitored using an egg candler. Virus inoculation is carried out by injection of virus stock into the allantoic cavity using a needle. After 2 days of incubation at 37 degrees C, the eggs are chilled for at least 4 hr at 4 degrees C. The eggshell above the air sac and the chorioallantoic membrane are then carefully opened, and the allantoic fluid containing the virus is harvested. The fluid is cleared from debris by centrifugation, aliquoted and transferred to -80 degrees C for long-term storage. The large amount (5-10 ml of virus-containing fluid per egg) and high virus titer which is usually achieved with this protocol has made the usage of eggs for virus preparation our favorable method, in particular for in vitro studies which require large quantities of virus in which high dosages of the same virus stock are needed.
引用
收藏
页数:6
相关论文
共 10 条
[1]  
Centers for Disease Control and Prevention (CDC), 1976, MMWR-MORBID MORTAL W, V59, P1057
[2]   Influenza and the challenge for immunology [J].
Doherty, PC ;
Turner, SJ ;
Webby, RG ;
Thomas, PG .
NATURE IMMUNOLOGY, 2006, 7 (05) :449-455
[3]   REPLICATION AND PLAQUE ASSAY OF INFLUENZA VIRUS IN AN ESTABLISHED LINE OF CANINE KIDNEY CELLS [J].
GAUSH, CR ;
SMITH, TF .
APPLIED MICROBIOLOGY, 1968, 16 (04) :588-&
[4]   Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection [J].
Ito, T ;
Suzuki, Y ;
Takada, A ;
Kawamoto, A ;
Otsuki, K ;
Masuda, H ;
Yamada, M ;
Suzuki, T ;
Kida, H ;
Kawaoka, Y .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3357-3362
[5]   Emergence and pandemic potential of swine-origin H1N1 influenza virus [J].
Neumann, Gabriele ;
Noda, Takeshi ;
Kawaoka, Yoshihiro .
NATURE, 2009, 459 (7249) :931-939
[6]   THE ROLE OF AMNIOTIC PASSAGE IN THE EGG-ADAPTATION OF HUMAN INFLUENZA-VIRUS IS REVEALED BY HEMAGGLUTININ SEQUENCE ANALYSES [J].
ROBERTSON, JS ;
NICOLSON, C ;
MAJOR, D ;
ROBERTSON, EW ;
WOOD, JM .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :2047-2051
[7]   Pathogenesis of influenza-induced acute respiratory distress syndrome [J].
Short, Kirsty R. ;
Kroeze, Edwin J. B. Veldhuis ;
Fouchier, Ron A. M. ;
Kuiken, Thijs .
LANCET INFECTIOUS DISEASES, 2014, 14 (01) :57-69
[8]  
Szretter K J., 2006, CURRENT PROTOCOLS MI
[9]   Pathogenicity of influenza viruses with genes from the 1918 pandemic virus:: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice [J].
Tumpey, TM ;
García-Sastre, A ;
Taubenberger, JK ;
Palese, P ;
Swayne, DE ;
Pantin-Jackwood, MJ ;
Schultz-Cherry, S ;
Solórzano, A ;
Van Rooijen, N ;
Katz, JM ;
Basler, CF .
JOURNAL OF VIROLOGY, 2005, 79 (23) :14933-14944
[10]   Continuing challenges in influenza [J].
Webster, Robert G. ;
Govorkova, Elena A. .
ANTIMICROBIAL THERAPEUTICS REVIEWS: INFECTIOUS DISEASES OF CURRENT AND EMERGING CONCERN, 2014, 1323 :115-139